PureTech appoints Julie Krop as Chief Medical Officer
Clinical-stage biotherapeutics company PureTech has appointed Julie Krop as Chief Medical Officer.
Krop will oversee all clinical development, Regulatory, CMC, and medical affairs for the company’s advancing Wholly Owned Pipeline.
Daphne Zohar, Founder and Chief Executive Officer of PureTech, said: “Julie is a biopharmaceutical industry veteran with a wide breadth of expertise across multiple therapeutic areas and orphan indications.
We believe her expertise in mid- to late-stage clinical development, in addition to her extensive experience as a board-certified physician and leader in regulatory affairs, will be important assets as we advance our lead programme.”